BeOne Medicines (ONC) Non-Current Assets (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Non-Current Assets data on file, last reported at $2.0 billion in Q1 2026.

• On a quarterly basis, Non-Current Assets changed 0.38% year-over-year to $2.0 billion in Q1 2026; TTM through Mar 2026 was $2.0 billion, a 0.38% change from a year earlier, with the FY2025 full-year figure at $2.0 billion, up 1.33% from the prior year.
• Non-Current Assets for Q1 2026 stood at $2.0 billion, roughly flat from $2.0 billion in the prior quarter.
• Over the last five years, Non-Current Assets for ONC reached as high as $2.0 billion in Q2 2025 and fell as low as $976.8 million in Q3 2022.
• Historically, Non-Current Assets has averaged $1.6 billion across 5 years, with a median of $1.8 billion in 2024.
• Across the five-year window, Non-Current Assets soared 57.82% in 2022 and gained 0.38% in 2026, its largest moves.
• Year by year, Non-Current Assets stood at $1.2 billion in 2022, then soared by 36.65% to $1.6 billion in 2023, then increased by 20.44% to $1.9 billion in 2024, then advanced by 1.33% to $2.0 billion in 2025, then retreated by 0.14% to $2.0 billion in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $2.0 billion in Q1 2026, $2.0 billion in Q4 2025, and $2.0 billion in Q3 2025.